These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 25822610

  • 1. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS, Polinski JM, Fulchino LA, Isaman DL, Gagne JJ.
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [Abstract] [Full Text] [Related]

  • 2. Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness.
    Kesselheim AS, Gagne JJ.
    Drug Saf; 2015 Oct; 38(10):849-53. PubMed ID: 26105011
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.
    Seoane-Vazquez E, Rodriguez-Monguio R, Hansen R.
    Clin Drug Investig; 2016 Apr; 36(4):281-92. PubMed ID: 26818406
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, Yang Y, Yu LX, Woodcock J.
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Understanding the scientific issues embedded in the generic drug approval process.
    Welage LS, Kirking DM, Ascione FJ, Gaither CA.
    J Am Pharm Assoc (Wash); 2001 Oct; 41(6):856-67. PubMed ID: 11765111
    [Abstract] [Full Text] [Related]

  • 9. Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.
    van der Meersch A, Dechartres A, Ravaud P.
    PLoS One; 2011 Oct; 6(8):e23611. PubMed ID: 21858184
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Brand and generic medications: are they interchangeable?
    Al-Jazairi AS, Bhareth S, Eqtefan IS, Al-Suwayeh SA.
    Ann Saudi Med; 2008 Oct; 28(1):33-41. PubMed ID: 18299655
    [Abstract] [Full Text] [Related]

  • 12. Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.
    Gupta R, Bollyky TJ, Cohen M, Ross JS, Kesselheim AS.
    BMJ; 2018 Mar 19; 360():k831. PubMed ID: 29555641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Some thoughts on drug interchangeability.
    Chow SC, Song F, Chen M.
    J Biopharm Stat; 2016 Mar 19; 26(1):178-86. PubMed ID: 26366703
    [Abstract] [Full Text] [Related]

  • 15. Community pharmacists' understanding and perceptions of FDA therapeutic equivalence standards.
    Euen BJ, Fadda HM.
    Res Social Adm Pharm; 2019 Jan 19; 15(1):77-83. PubMed ID: 29567088
    [Abstract] [Full Text] [Related]

  • 16. Evaluating the bioavailability and bioequivalence of generic medications.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2010 Jan 19; 48(1):13-6. PubMed ID: 20102127
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
    Dupont AG, Heller F.
    Acta Clin Belg; 2009 Jan 19; 64(5):406-14. PubMed ID: 19999388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.